The role of C/EBP-β LIP in multidrug resistance
- PMID: 25766403
- DOI: 10.1093/jnci/djv046
The role of C/EBP-β LIP in multidrug resistance
Abstract
Background: Chemotherapy triggers endoplasmic reticulum (ER) stress, which in turn regulates levels of the active (LAP) and the natural dominant-negative (LIP) forms of the transcription factor C/EBP-β. LAP upregulates and LIP downregulates the multidrug resistance (MDR) protein P-glycoprotein (Pgp), but it is not known how critical is their role in establishing MDR.
Methods: Cell viability was quantitated by crystal violet staining and measuring absorbance at 540nm. Expression of various proteins was determined by immunoblotting. mRNA levels were determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). LIP and LAP were overexpressed using expression plasmids followed by selection with blasticidin. Tumor cells expressing doxycycline-inducible LIP were orthotopically implanted in mice (n = 15 mice per group), and tumor size was measured daily by caliper. Tumor sections were stained with hematoxylin and eosin and immunostained for Pgp, proliferation, and ER stress markers.
Results: MDR cells do not express basal, chemotherapy-triggered, or ER stress-triggered LIP and fail to activate the CHOP-caspase-3 death-triggering axis upon ER stress or chemotherapy challenge. Overexpression of LIP reversed the MDR phenotype in vitro and in tumors implanted in mice. LIP was undetectable in MDR cells, probably due to its ubiquitination, which was 3.56-fold higher, resulting in lysosomal and proteasomal degradation of LIP.
Conclusions: Spontaneous and drug-selected MDR cells lack LIP, which is eliminated by ubiquitin-mediated degradation. Loss of LIP drives MDR not only by increasing Pgp expression but also by a two-fold attenuation of ER stress-triggered cell death.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer.J Exp Clin Cancer Res. 2018 Nov 27;37(1):286. doi: 10.1186/s13046-018-0967-0. J Exp Clin Cancer Res. 2018. PMID: 30482226 Free PMC article.
-
C/EBP-beta regulates endoplasmic reticulum stress-triggered cell death in mouse and human models.PLoS One. 2010 Mar 3;5(3):e9516. doi: 10.1371/journal.pone.0009516. PLoS One. 2010. PMID: 20209087 Free PMC article.
-
Sorcin induces a drug-resistant phenotype in human colorectal cancer by modulating Ca(2+) homeostasis.Cancer Res. 2011 Dec 15;71(24):7659-69. doi: 10.1158/0008-5472.CAN-11-2172. Epub 2011 Nov 3. Cancer Res. 2011. PMID: 22052463
-
Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.Curr Opin Oncol. 1998 Aug;10 Suppl 1:S15-9. Curr Opin Oncol. 1998. PMID: 9801854 Review.
-
CCAAT/enhancer binding protein β in relation to ER stress, inflammation, and metabolic disturbances.Biomed Res Int. 2015;2015:324815. doi: 10.1155/2015/324815. Epub 2015 Jan 28. Biomed Res Int. 2015. PMID: 25699273 Free PMC article. Review.
Cited by
-
Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma.Cell Mol Life Sci. 2019 Feb;76(3):609-625. doi: 10.1007/s00018-018-2967-9. Epub 2018 Nov 14. Cell Mol Life Sci. 2019. PMID: 30430199 Free PMC article.
-
PARP1 rs1805407 Increases Sensitivity to PARP1 Inhibitors in Cancer Cells Suggesting an Improved Therapeutic Strategy.Sci Rep. 2019 Mar 1;9(1):3309. doi: 10.1038/s41598-019-39542-2. Sci Rep. 2019. PMID: 30824778 Free PMC article.
-
Doxorubicin resistant cancer cells activate myeloid-derived suppressor cells by releasing PGE2.Sci Rep. 2016 Apr 1;6:23824. doi: 10.1038/srep23824. Sci Rep. 2016. PMID: 27032536 Free PMC article.
-
Interplay between P-Glycoprotein Expression and Resistance to Endoplasmic Reticulum Stressors.Molecules. 2018 Feb 6;23(2):337. doi: 10.3390/molecules23020337. Molecules. 2018. PMID: 29415493 Free PMC article. Review.
-
Integrating Enzymatic Self-Assembly and Mitochondria Targeting for Selectively Killing Cancer Cells without Acquired Drug Resistance.J Am Chem Soc. 2016 Dec 14;138(49):16046-16055. doi: 10.1021/jacs.6b09783. Epub 2016 Dec 1. J Am Chem Soc. 2016. PMID: 27960313 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous